A BioNTech-led team designed a cocktail of mRNAs that instruct cells to produce four cancer-fighting molecules.
Geelsu Hwang of the School of Dental Medicine and colleagues are developing a smart dental implant that resists bacterial growth and generates its own electricity through chewing and brushing to power
The biotech will use the funds for a slate of gene insertion programs for liver disorders out of the lab of gene therapy pioneer Jim Wilson, M.D., Ph.D. at Penn.
Sixteen years after their research at Penn paved the way for billions to be vaccinated against COVID-19, two scientists from Penn have been honored with the Breakthrough Prize.
According to a new CBRE report, life science firms are on pace for a record year. Plus, a look at lab space occupancy.
One of Tachi’s newly born legacy biotechs raises $135M and enlists an A-list board to advance late-stage vaccine
Tachi Yamada's biotechs are continuing to make news.
Penn Medicine and Wharton Social Impact Initiative Launch New $5 Million Investment Initiative for Businesses that Improve Health of Philadelphians
Three start-up companies will be the first to receive investment from the Fund for Health, a joint partnership between Penn Medicine and the Wharton Social Impact Initiative.
Penn to play key role in the inaugural NSF Mid-Atlantic I-Corps Hub to advance entrepreneurship and technology commercialization training
PCI is proud to announce that Penn is one of the schools chosen to participate in the National Science Foundation’s new innovative I-Corps Hub initiative.
The award, one of the largest in medicine and science in the U.S., has been given for the last 20 years by Albany Medical Center to those who have altered and positively impacted the course
The U.S. FDA has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists at Penn.